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PCLINICAL RESEARCH Myocardial Infarction
Mobilization of Bone Marrow-Derived
Oct-4 SSEA-4 Very Small Embryonic-Like Stem
Cells in Patients With Acute Myocardial Infarction
Wojciech Wojakowski, MD, PHD,* Michał Tendera, MD, PHD, FACC,* Magda Kucia, PHD,†
Ewa Zuba-Surma, PHD,† Edyta Paczkowska, MD, PHD,‡ Joanna Ciosek, MD,*
Maciej Hałasa, MD, PHD,‡ Marek Kro´l, MD, PHD,§ Maciej Kazmierski, MD, PHD,*
Paweł Buszman, MD, PHD, FACC,*§ Andrzej Ochała, MD, PHD,* Janina Ratajczak, MD, PHD,†
Bogusław Machalin´ski, MD, PHD,‡ Mariusz Z. Ratajczak, MD, PHD†‡
Katowice, Szczecin, and Ustron, Poland; and Louisville, Kentucky
Objectives This study sought to assess of the mobilization of nonhematopoietic very small embryonic-like stem cells
(VSELs) in acute myocardial infarction (MI).
Background Acute MI induces mobilization of bone marrow stem cells. Recently, a rare population of VSELs, expressing
markers of embryonic pluripotent stem cells (PSCs), was identified in adult murine bone marrow and human
umbilical cord blood.
Methods Thirty-one patients with acute MI and 30 healthy subjects were enrolled. Blood was sampled on admission, after
24 h, and 5 days later. Erythrocytes were lysed and linCD45 VSELs were isolated using a live cell sorting sys-
tem (FACSAria, Beckton Dickinson, San Jose, California).
Results In healthy subjects the median number of circulating VSELs was very low (median 0.8 [range 0 to 1.3]) cells/l.
In acute MI, VSELs were mobilized early (median 2.7 [range 0.2 to 3.9] cells/l; p  0.001) and remained ele-
vated after 24 h and 5 days (median 4.7 [range 0.2 to 6.4] cells/l; p  0.003, and median 2.6 [range 0.3 to
3.6] cells/l; p  0.03, respectively). The mobilization of VSEL was significantly reduced in patients older than
50 years and with diabetes in comparison with younger and nondiabetic patients. Circulating VSELs were small
(7 to 8 m) and enriched in the messenger ribonucleic acid of PSC markers (Oct-4, Nanog), cardiac lineage
(GATA-4, Nkx2.5/Csx, MEF2C), and endothelial (VE-cadherin) markers. The presence of PSC markers (Oct-4,
SSEA-4) and the chemokine receptor CXCR4 in circulating VSELs was confirmed at the protein level by immuno-
fluorescent staining and ImageStream system (Amnis Corporation, Seattle, Washington) analysis.
Conclusions Acute MI induced mobilization of VSELs expressing pluripotent markers, early cardiac and endothelial markers,
and chemokine receptor CXCR4. (J Am Coll Cardiol 2009;53:1–9) © 2009 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.09.029(
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scute myocardial infarction (MI) induces a generalized
nflammatory response reflected by increased plasma levels
f chemoattractants leading to subsequent mobilization of
tem and progenitor cells from the bone marrow (BM)
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008, accepted September 8, 2008.1–5). These circulating cells represent predominantly com-
itted lineages such as granulocytes, lymphocytes, and
onocytes, but also much smaller subpopulations of mono-
otent and multipotent cells, which may play a role in
ardiac and endothelial repair. Earlier studies showed that
See page 10
hese cells released into peripheral blood (PB) after the acute
I consist of hematopoietic stem cells (HSCs), endothelial
rogenitor cells (EPCs), and multipotent mesenchymal
tromal cells (2,3,6). In patients with acute MI, we found
ignificant up-regulation of early cardiac and endothelial
ineage markers in circulating mononuclear cells (MNCs)
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Oct-4 Cells in MI December 30, 2008/January 6, 2009:1–9(3). Kucia et al. (1) showed that
adult murine BM harbors a
population of nonhematopoietic
Sca-1linCD45 cells enriched
for GATA-4 and Nkx2.5/Csx
that also expressed CXCR4,
which migrated to stromal-derived
factor (SDF)-1 gradient and un-
derwent rapid mobilization into
PB in experimental MI. Our re-
cently published data confirmed
that murine BM-derived Sca-
1linCD45CXCR4 cells
express not only cardiac and
endothelial but also several de-
velopmental markers character-
istic of embryonic pluripotent
stem cells (PSCs), such as
Oct-4, Nanog, and SSEA-1.
Based on their small size, mor-
phology, and the presence of
PSC markers, these cells were
named very small embryonic-like
tem cells (VSELs). Murine VSELs can differentiate into
ell lineages from all 3 germ layers, including mesoderm-
erived cardiomyocytes. This population of primitive cells
an be isolated from the BM and PB using a multiparameter
ive cell sorting technique (7–9). We hypothesized that
SELs are the progeny of epiblast-derived stem cells and
orm a population of quiescent PSCs deposited early in
rganogenesis in developing BM and other organs (brain,
eart) (10). As mentioned earlier, experimental MI in mice
s associated with the mobilization of VSELs into PB;
owever, there are no data confirming the presence of such
rimitive stem cells in patients with acute MI (11–13).
In the present study, we provide evidence for the first
ime in humans using several experimental strategies show-
ng that acute MI induces mobilization of VSELs express-
ng PSC markers.
ethods
atient population. We studied 31 patients with acute
T-segment elevation MI referred within 12 h after the
ymptom onset for primary percutaneous coronary intervention
nd 30 healthy age- and sex-matched subjects (Table 1).
luorescence-activated cell sorting (FACS) analysis
nd sorting of circulating VSELs. Figure 1A shows the
rotocol of VSEL isolation and analysis. The PB samples
ere drawn on admission, 24 h after percutaneous
oronary intervention, and 5 days later. The VSELs
linCXCR4CD45 cells that coexpress CD133 and
D34 antigens) were sorted using a multiparameter, live
terile cell sorting system (FACSAria, Beckton Dickinson,
an Jose, California) (Fig. 1B) and used for real-time
Abbreviations
and Acronyms
BM  bone marrow
EPC  endothelial
progenitor cell
HSC  hematopoietic stem
cell
LVEF  left ventricular
ejection fraction
MI  myocardial infarction
MNC  mononuclear cell
PB  peripheral blood
PSC  pluripotent stem
cell
RT-PCR  (real-time)
reverse transcriptase-
polymerase chain reaction
SDF  stromal-derived
factor
VSEL  very small
embryonic-like stem celleverse-transcriptase polymerase chain reaction (RT-PCR) cnd immunofluorescence and ImageStream system (ISS)
Amnis Corporation, Seattle, Washington) analysis (2,7)
Online Appendix).
T-PCR. This study used RT-PCR for analysis of mes-
enger ribonucleic acid (mRNA) levels for PSC (Oct-4,
anog), early myocardial (Nkx2.5/Csx, GATA-4,
EF2C), and endothelial (VE-cadherin) markers (Online
ppendix).
mmunofluorescent staining of VSELs. The VSELs were
tained with anti-SSEA-4, Oct-4, and CXCR4 monoclonal
ntibodies (Online Appendix).
SS analysis. After lysis of red blood cells and washing,
he nucleated fraction of PB cells was fixed, permeabil-
zed, and stained for Oct-4, CD45, lineage markers, and
XCR4. The PB-derived granulocytes and erythrocytes
ere stained for their specific markers. Samples were
nalyzed with ISS 100 (Online Appendix).
esults
obilization of Oct-4 VSELs in acute MI. In healthy
ubjects, the number of circulating VSELs was very low
median 0.8 cells/l, range 0 to 1.3 cells/l). In contrast, the
umber of VSELs was higher in acute MI patients than in
ontrol subjects early (12 h) after the onset of symptoms
median 2.7 cells/l, range 0.2 to 3.9 cells/l; p  0.001).
urther mobilization was observed after 24 h (median 4.7
ells/l, range 0.2 to 7.4 cells/l; p  0.003) (Fig. 2) and 5
ays (median 2.6 cells/l, range 0.3 to 3.6 cells/l; p 
emographic, Clinical, and Laboratoryharacteristics of P tients With Acute MI andontrol Group
Table 1
Demographic, Clinical, and Laboratory
Characteristics of Patients With Acute MI and
Control Group
Acute MI
(n  31)
Control
(n  30)
Age,  SD (mean yrs) 62.5 12.1 40.4 9.4*
Male, n (%) 20 (64) 19 (63)
History of CAD, n (%) 16 (51) —
Hypertension, n (%) 18 (58) 16 (53)
Diabetes, n (%) 8 (25) 7 (23)
Family history of CAD, n (%) 7 (22) 6 (20)
Smoking, n (%) 11 (35) 10 (33)
Total cholesterol, mmol/l 4.9 (4.0–5.7) 4.8 (4.0–5.5)
Creatinine, mol/l 112 (97–125) 109 (92–123)
Mean LVEF, % (range) 45.5 (25–60) 56.7 (50–62)*
Prior statins, n (%) 10 (32) 9 (30)
Prior ACEI, n (%) 12 (38) 11 (36)
Maximum troponin I, ng/ml 6.4 (1.4–100) —
Maximum CK-MB, U/l 124 (37–324) —
12-h leukocytes, 103 cells/l (range) 11.2 (6.3–15) 5.9 (4.0–8.8)†
24-h leukocytes, 103 cells/l (range) 12.7 (7.4–16.2) —
5-day leukocytes, 103 cells/l (range) 10.9 (5.1–14.2) —
Lymphocytes, 103 cells/l (range) 2.28 (0.8–3.9) 2.1 (0.7–3.7)
Granulocytes, 103 cells/l (range) 7.6 (4.0–14.7) 2.7 (2.1–4.3)
Hemoglobin, g/dl (mean  SD) 14.6 1.2 14.7 1.1
alues expressed as n (%) or median (range) unless otherwise specified. *p  0.03 control versus
I group. †p  0.0001 control versus MI group.
ACEI  angiotensin-converting enzyme inhibitor; CAD  coronary artery disease; CK-MB 
reatine kinase-MB; LVEF  left ventricular ejection fraction; MI  myocardial infarction.
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December 30, 2008/January 6, 2009:1–9 Oct-4 Cells in MI.03). Populations of CD34CD133VEGFR2 EPCs
nd CD34CXCR4 cells increased significantly in acute
I; however, the absolute numbers of cells were higher
Figure 1 Procedure of Isolation of VSELs From Peripheral Blood
Isolation of VSELs from peripheral blood nucleated cells by hypotonic lysis of eryth
Dickinson, San Jose, California) (A). Sorting was based on the immunophenotype
small events consistent with the size range of VSELs (5 to 7 m). Events containe
CD34, CD133, and CXCR4 (gate P2) and the absence of CD45 (gate P3), which re
Rob Flewell. (B) Sorting of the subpopulation of nonhematopoietic CD45linCD3
like stem cell.han VSELs (Table 2). xpression of PSC markers by RT-PCR and immuno-
uorescent staining. We found that the expression of PSC
arkers was significantly higher 12 h after MI (Oct-4: 17.9
s and sterile, live cell sorting using the FACSAria cell sorting system (Beckton
XCR4CD34CD133CD45) of the VSEL. Gating strategy enabled us to include
ate P1 were characterized by the absence of lineage markers and presence of
nt the population of VSELs (B). (A) Procedure flowchart. Figure illustration by
CD45CD133, and linCD45CXCR4 VSELs. VSEL  very small embryonic-rocyte
(linC
d by g
prese
4, lin4.3-fold; Nanog: 18.2  3.7-fold) than in control
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Oct-4 Cells in MI December 30, 2008/January 6, 2009:1–9ubjects. The highest levels of mRNA were detected 24 h
fter acute MI, at the same time as when the most
ignificant mobilization of VSELs occurred (Oct-4: 206 
2-fold; Nanog: 282  41-fold). After 5 days, levels of
RNA were no different from control subjects (Oct-4: 2.3
0.4-fold; Nanog: 2.3  0.38-fold) (Fig. 3).
The presence of the PSC markers Oct-4, SSEA-4, and
XCR4 was subsequently confirmed at the protein level
sing immunofluorescent staining. The VSELs sorted from
B were positive for nuclear transcription factor Oct-4, cell
urface antigen SSEA-4, and CXCR4 receptor by direct
mmunofluorescence staining (Fig. 4A). We noticed that 54
11.2% sorted VSELs express Oct-4 antigen. This corre-
ponds to our previously published data on mobilization of
SELs in a murine model (8).
ize and immunophenotype of VSELs. The population
f VSELs consists of nonhematopoietic cells negative for
ineage markers and CD45 antigen (linCD45) and pos-
tive for CXCR4, CD133, and CD34 antigens as shown by
mmunofluorescent staining and ISS. Expression of the
SC markers Oct-4 and SSEA-4 was confirmed in popu-
ation of small cells (approximately 7 to 8 m). Direct
Figure 2 Mobilization of linCD133CD45 VSELs
Mobilization of cells shown as change in absolute number of cells per microli-
ter of peripheral blood in patients with acute myocardial infarction (MI) in com-
parison to healthy control subjects (CTRL). *p  0.001 versus CTRL; **p 
0.003 versus CTRL. VSEL  very small embryonic-like stem cells.
obilization of CD34CD133VEGFR2 EPCs, CD34CXCR4 CelinCD133CD45 VSELs in Patients With Acute MI in Comparison
Table 2 Mobilization of CD34
CD133VEGFR2 EPCs, CD34
linCD133CD45 VSELs in Patients With Acute MI in
Control
Acute MI
Admission
p Value
Versus
Control
Ac
EPC, cells/l,
median (range)
1.6 (0–2.1) 3.7 (0.1–5.6) 0.003 5.7
CD34CXCR4, cells/l,
median (range)
1.9 (0–3.2) 5.4 (0.4–7.7) 0.0001 7.3
VSEL, cells/l,
median (range)
0.8 (0–1.3) 2.7 (0.2–3.9) 0.001 4.7PC  endothelial progenitor cells; MI  myocardial infarction; VSEL  very small embryonic-like stem cSS-based comparison of mobilized VSELs with other
opulations of circulating nucleated cells (monocytes, gran-
locytes) showed that VSELs are significantly smaller and
ave distinct morphology (Fig. 4B).
xpression of early cardiac and endothelial markers in
irculating VSELs by RT-PCR. The highest relative
xpression level of early cardiac markers was detected 24 h
fter acute MI for GATA-4 (210  34-fold), Nkx2.5/Csx
174  28-fold), MEF2C (209  32-fold), and VE-
adherin (3,884 37-fold). After 5 days, relative expression
evels of GATA-4 (1.7  0.6-fold), Nkx2.5/Csx (2 
.5-fold), and VE-cadherin (3.3  0.9-fold) were compa-
able to control subjects, whereas expression of MEF2C
emained higher (97.5  19-fold) (Fig. 5).
lasma concentrations of chemokines, growth factors,
ytokines, and inflammatory markers. In acute MI, the
p-regulation of plasma levels of chemoattractants (SDF-1,
GF, SCF, G-CSF, and VEGF) was found (Online
able). The number of circulating VSELs in MI patients
ositively correlated with levels of SDF-1. More informa-
ion is available in the Online Appendix.
linical and demographic correlates of VSELs mobiliza-
ion. The mobilization of VSELs was significantly higher
n younger (age 50 years) compared with older patients
median 4.9 cells/l, range 0 to 6.4 cells/l vs. median 2.7
ells/l, range 0.2 to 5.1 cells/l; p  0.05). In diabetic
atients the number of circulating VSELs was significantly
ower than in nondiabetic patients (median 1.9 cells/l,
ange 0 to 2.3 cells/l vs. median 4.8 cells/l, range 0.2 to
.2 cells/l; p  0.05). In addition, mobilization of VSELs
as impaired in patients with a left ventricular ejection
raction (LVEF) 40% compared with an LVEF 40%
median 3.3 cells/l, range 0 to 4.9 cells/l vs. median 4.7
ells/l, range 0.4 to 6.4 cells/l; p 0.05). The differences
ere significant after 12 and 24 h, but not after 5 days. The
umber of VSELs had a significantly negative correlation
ith maximum levels of troponin I on admission (R 
0.41; p 0.03) and after 24 h (R0.34; p 0.04), but
ot after 5 days (R  0.31; p  0.45). Similar negative
orrelations were found in relation to maximum activity of
K-MB (on admission: R  0.45; p  0.033; after 24 h:
 0.39; p  0.042; after 5 days R  0.21; p  0.23).
dh Healthy Control Subjects
4 Cells, and
parison With Healthy Control Subjects
I
p Value
Versus
Control
p Value
Versus
Admission
Acute MI
Day 5
p Value
Versus
Control
p Value
Versus
Admission
) 0.0001 0.003 5.1 (0.2–7.3) 0.0001 0.03
.7) 0.0001 0.003 6.8 (0.3–9.5) 0.0001 0.03
.4) 0.001 0.003 2.6 (0.3–3.6) 0.03 NSls, anWit
CXCR
Com
ute M
24 h
(0–8.1
(0.3–9
(0.3–7ell.
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December 30, 2008/January 6, 2009:1–9 Oct-4 Cells in MIiscussion
dult BM harbors various populations of cells that can
otentially contribute to myocardial and endothelial repair
7,14–18). Data from the experimental model of acute MI
n mice showed that VSELs are mobilized into PB in
esponse to myocardial ischemia (11). Furthermore, in-
ramyocardial injection of VSELs was more efficient than
SCs and placebo at improving global and regional left
entricular contractility, left ventricular end-systolic diame-
er, and systolic thickening, as well as reducing myocardial
ypertrophy. This effect was obtained using a small total
umber of VSELs (10,000 cells), whereas a much higher
umber of HSCs (100,000 cells) was not effective (19).
SELs circulate in PB in adult humans. Recently,
SELs were identified in human cord blood, but there were
o data on their presence in adults (20). In the present work
e showed for the first time that VSELs are present in the
B in healthy adult subjects and undergo significant mo-
ilization in patients with acute MI. We used an FACS
ive cell sorting system to define the immunophenotype of
uman VSELs and to isolate these cells for subsequent
nalyses. We showed that the number of circulating
SELs increases 12 h after the onset of the symptoms,
eaching a maximum after 24 h and remaining elevated
fter 5 days. The time course of the VSEL mobilization
s similar to that for EPCs; however, the absolute cell
umber is significantly lower and decreases more rapidly
fter acute MI.
haracteristics of murine and human VSELs. In adult
urine BM, VSELs comprise a rare population (approxi-
ately 0.01%) of MNCs (7,21). In mice, VSELs are
onhematopoietic Sca-1linCD45 cells expressing
Figure 3 Expression of Pluripotent Stem Cell Markers in Circul
Relative changes in expression of pluripotent stem cells markers in circulating VSE
MI and healthy controls measured by RT-PCR. Expression of each gene showed as
tion; RT-PCR  (real-time) reverse transcriptase-polymerase chain reaction; VSEL arkers of PSCs Oct-4, Nanog, and SSEA-1 at the mRNA pnd protein levels. Data from electron microscopy and ISS
howed that VSELs have a morphology consistent with
mbryonic stem cells. These cells are small (approximately
.6 m in diameter) and have a large nucleus surrounded by
narrow rim of cytoplasm with numerous mitochondria and
pen-type chromatin (7,21). Approximately 5% to 10% of
urified VSELs form in coculture with C2C12 myoblast
ine spheres that resemble embryoid bodies. Cells derived
rom these spheres can be expanded if replated over a
2C12 feeder layer or differentiated after replating into
issue-specific differentiation media into cells representing
ll 3 germ layers including cardiac myocytes (7,9,21). In the
resent work, the expression of mRNA for early develop-
ental markers was shown in circulating VSELs using
T-PCR, which confirmed their enrichment in mRNA for
ct-4 and Nanog. The highest relative expression level of
RNA for these genes was detected 24 h after acute MI, at
he same time when the most significant mobilization of
SELs occurred. The presence of PSC markers Oct-4 and
SEA-4 was subsequently confirmed at the protein level
sing immunofluorescent staining and ISS analysis. The
SS is an imaging system that integrates the information
btained by FACS and immunofluorescence, allowing a
ombination of the data on cell morphometry and quanti-
ative image analysis, for example, information on colocal-
zation of multiple cellular markers (21). The VSELs were
ositive for nuclear transcription factor Oct-4 and cell
urface antigen SSEA-4. These small (approximately 7 m)
ct-4 and SSEA-4 –positive cells coexpressed CD34,
D133, and CXCR4 and were negative for lineage markers
nd the panhematopoietic marker CD45. The presence of
XCR4 on the surface of the cells was consistent with the
VSELs
lated by sterile, live cell sorting from the peripheral blood of patients with acute
ifference results compared to healthy subjects (n  15). MI  myocardial infarc-
small embryonic-like stem cell. *p  0.003; **p  0.00001; ***p  NS.ating
Ls iso
fold d
veryreviously described VSEL profile (7). Moreover, we no-
t
i
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Oct-4 Cells in MI December 30, 2008/January 6, 2009:1–9iced that approximately 50% to 60% of circulating VSELs
n PB in acute MI patients express Oct-4 at a protein level
Figure 4 Analysis of VSELs by Immunofluorescent Staining and
Immunofluorescent staining of peripheral blood-derived linCD45CD133 VSELs sor
CXCR4 and SSEA-4 are visualized in the cellular membrane, and Oct-4 is visualized in
performed on cells isolated from 4 independent sorts. (B) Circulating human VSELs a
linCD45CXCR4 VSELs was confirmed at the single-cell level. The size of VSELs wa
patients with acute MI. The size of the cells was calculated by IDEAS software (Amnishat corroborates with our previously published data on cobilization of VSELs in mice (8). Comparison of mobi-
ized VSELs with other populations of circulating nucleated
eStream System
h FACSAria (A). The VSELs express SSEA-4, Oct-4, and CXCR4 at the protein level.
cleus. Nuclei are stained with 4=,6-diamidino-2-phenylindole (DAPI). Staining was
by the ImageStream system. Expression of Oct-4 and SSEA-4 in
pared with granulocytes and erythrocytes derived from the peripheral blood of
ration, Seattle, Washington). Scale bar  10 m. Abbreviations as in Figure 3.Imag
ted wit
the nu
nalyzed
s com
Corpoells (monocytes, granulocytes) showed that not only are
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December 30, 2008/January 6, 2009:1–9 Oct-4 Cells in MISELs significantly smaller, but they also have a distinct
orphology. We noticed that similar to mice, the size of
uman VSELs is slightly smaller than erythrocytes. Never-
heless, human circulating VSELs in adult patients are
arger than those isolated from human neonatal umbilical
ord blood (3 to 5 m) as well as murine (3 to 4 m)
M-derived VSELs (11,20).
obilization of VSELs as a hypothetical reparatory
echanism in acute MI. It is hypothesized that stem cells
esiding in BM and other tissues to reduce the cardiac
schemic injury must undergo mobilization and subse-
uently home and engraft into the myocardium (22–26).
ecause BM is also a potential source of cardiac stem cells,
he mobilization of cardiac stem cells from the BM may be
n additional physiological pathway to replenish these stem
ells (27). Shintani et al. (5) described for the first time a
apid increase of EPC number after acute MI. Massa et al.
2) documented mobilization of both HSCs and EPCs in
atients with acute MI. The number of circulating cells
eached a maximum early, within a few hours after the onset
f symptoms, decreased after 1 week, and returned to a level
omparable to that of healthy subjects within 2 months. In
ddition to EPCs and HSCs, other less well defined
ubpopulations (c-met, c-kit, mesenchymal stromal cells)
ere also mobilized in acute MI (28).
irculating human VSELs are enriched in mRNA for
arly cardiac and endothelial markers. We found that
irculating human VSELs are significantly enriched for
RNA for cardiac lineage (GATA-4, Nkx2.5/Csx,
Figure 5 Expression of Early Cardiac and Endothelial Markers i
Relative changes in expression of early cardiac and endothelial markers in circulat
acute MI and healthy control subjects as measured by RT-PCR. Expression of each
*p  0.003; **p  0.00001; ***p  NS. Abbreviations as in Figure 3.EF2C) and endothelial (VE-cadherin) markers. The 4ighest relative expression level of mRNA for these genes
as detected 24 h after acute MI. The decrease in mRNA
xpression probably could be related to “back-homing” to
he BM of mobilized cells not incorporated in the myocar-
ium. Other possible mechanisms could also be involved,
uch as: 1) an increase in expression of cardiac committed
enes in VSELs by signals released from damaged myocar-
ium; or 2) some point-selective mobilization of VSELs
lready enriched in cardiac markers (committed to myocar-
ial lineage). Our previous data from patients with acute MI
howed significant mobilization of CD34CXCR4 cells
arly in acute MI. Parallel to the release of CD34CXCR4
ells, we found a significant increase of the mRNA for
arly myocardial, muscle, and endothelial markers in the
B MNCs, but we were not able to show which popula-
ion of circulating MNCs was responsible for the enrich-
ent in the tissue-specific markers (3). In a murine model
f MI, it was consistently shown that stem cells are
obilized into PB and the relative increase in expression
evels of cardiac and endothelial markers correlates with
tem cell mobilization (1).
The presence of Oct-4 cells in adult murine BM raises
n important question about their ability to differentiate
nto cardiomyocytes. Pallante et al. (29) showed that the
urine BM contains cells capable of cardiogenic differen-
iation that give rise to the population of spontaneously
ontracting cardiomyocytes expressing the cardiac structural
roteins, beta-adrenergic receptors and connexins. These
ells were identified as rare (0.05% of BM MNCs) Oct3/
culating VSELs
ELs isolated by sterile, live cell sorting from the peripheral blood of patients with
was shown as a fold difference result compared with healthy subjects (n  15).n Cir
ing VS
genec-kitCXCR4Sca-1CD34CD45 cells localized
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Oct-4 Cells in MI December 30, 2008/January 6, 2009:1–9djacent to the osteoblastic niche. Thus, this study some-
ow supports our results showing that the population of
obile nonhematopoietic Oct-4CXCR4CD133 cells
s enriched for the cardiac markers and capable of cardiac
ifferentiation (1,7).
he number of circulating VSELs correlates with plasma
DF-1 levels. We found that although the number of
irculating VSELs in acute MI positively correlated with
evels of SDF-1, there was no significant correlation with
ther cytokines, growth factors, chemokines, or inflam-
atory markers. This correlation between SDF-1 level
nd the circulating VSEL expressing SDF-1– binding
eceptor CXCR4 seems to be biologically important.
urine BM-derived VSELs express the CXCR4 as well
s other receptors for cytokines and growth factors (c-met
nd leukemia inhibitory factor receptor). We have previ-
usly reported that the population of murine BM-derived
ells expressing cardiac markers migrated to the homog-
nates prepared from infarcted myocardium in a SDF-1/
XCR4, leukemia inhibitory factor/leukemia inhibitory
actor receptor, and HGF/c-met dependent manner
1,4,7).
obilization of VSELs is decreased in older patients
ith diabetes and reduced LVEF. Several factors, includ-
ng age, presence of diabetes, and the use of statins, can
nfluence the mobilization of cells into the PB. In murine
odels, age seems to be the most important determinant of
obilized VSELs and level of expression of PSC markers in
hese cells (7). We report that the mobilization of VSELs
as significantly more efficient in younger patients than in
lder patients. This finding is consistent with our previous
ata showing that the number of circulating CD34CXCR4
ells is significantly reduced in patients older than 50 years
12). To support this clinically relevant observation, we
reviously reported that in 1-year-old mice the number of
ca-1linCD45 VSELs in the BM is significantly de-
reased compared with young 1-month-old animals. Data
rom animal models showed that both younger and older
ice had a similar time course and number of circulating
SELs after the acute MI; however, the level of expression
f PSC markers in circulating VSEL was significantly lower
n older animals (11). In diabetic patients, the number of
obilized pluripotent VSELs is lower than in nondiabetics.
t is worth mentioning that so far no study has investigated
he influence of diabetes on tissue distribution and mobili-
ation of PSCs. However, diabetes is associated with
educed mobilization, functional capacity, and survival of
PCs as well as promoting the senescence of cardiac stem
ells (30,31).
Mobilization of VSELs was also impaired in our study in
atients with reduced LVEF. In addition, the number of
SELs showed significant negative correlations with car-
iac necrosis markers, which suggests that reduced mobili-
ation of VSELs is associated with larger infarct size and a migher degree of impairment of the left ventricular contrac-
ility. This could be potentially explained by the fact that
roteases are probably more abundantly released from the
arger necrotic areas of myocardium and may negatively
ffect stability of certain stem cell-mobilizing chemoattrac-
ants. To support this, SDF-1 is a very-well-known sub-
trate for several tissue proteases (32). Current findings are
onsistent with our previous data suggesting that the num-
ers of circulating CD34CXCR4 cells correlate posi-
ively with LVEF and negatively with markers of myocar-
ial necrosis and N-terminal pro-B-type natriuretic peptide
n patients with acute MI (13). In the prospective 1-year
ollow-up of 55 patients with acute MI, we showed that the
obilization of CD34CXCR4 cells in the acute phase
ositively correlated with LVEF after 1 year (12). In 15
atients followed up using cardiac magnetic resonance
maging, we showed that mobilization of CD34CXCR4
ells in acute MI inversely correlated with the parameters of
eft ventricular end-systolic and end-diastolic remodeling,
nfarct area (delayed enhancement), and number of seg-
ents showing impaired perfusion after infusion of adeno-
ine (3,12). The association between the mobilization of
tem and progenitor cells was confirmed by Leone et al.
33), who showed that a higher number of CD34 cells
ssessed 1 year after the MI is associated with better
mprovement of LVEF. Numaguchi et al. (34) showed that
n patients with acute MI the capability of mobilized EPCs
o differentiate into mature endothelial cells may be associ-
ted with improved recovery of LVEF, lower end-systolic
olume, and decreased infarct size. However, these findings
eed confirmation in larger populations of patients before
se of the stem cell number as the cardiac recovery marker
an be recommended.
The search for the most suitable cell for cardiac repair
ontinues, and cells showing the features of PSCs (e.g.,
SELs) are good candidates for further studies in this area.
he VSELs can be easily isolated from the BM using a live
ell sorting system. In addition, murine VSELs can be
xpanded and differentiated into cardiomyocytes. We are
ware that the obvious limitation of our current study is the
ack of direct proof that the human PB-derived VSELs can
ifferentiate into the cardiac myocytes similar to their
urine counterparts. Indeed, this issue needs further inves-
igation (8). In conclusion, we believe that human VSELs
ight be potentially useful in future clinical studies in
atients with ischemic cardiomyopathy, providing that the
echnical issues with their large-scale isolation, expansion,
nd differentiation are resolved.
This study supports the hypothesis that a rare population
f VSELs expressing markers of PSCs (Oct-4, Nanog,
SEA-4) as well as early cardiac and endothelial markers is
obilized to the PB in acute MI. Mobilization of VSELs is
educed in older patients with high levels of cardiac necrosis
arkers, reduced LVEF, and diabetes.
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APPENDIX
or expanded Methods and Results sections including a table (levels of
hemoattractants) and figure (VSEL mobilization), please see the online
ersion of this article.
